The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cancer Early Detection and Diagnosis Market Research Report 2024

Global Cancer Early Detection and Diagnosis Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1743064

No of Pages : 85

Ask Your Query

Synopsis
Cancer early detection and diagnosis are crucial in improving treatment outcomes and patient survival rates. Early detection involves identifying cancer at its earliest stages, even before symptoms become apparent.

Global Cancer Early Detection and Diagnosis market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cancer Early Detection and Diagnosis market research.

Key companies engaged in the Cancer Early Detection and Diagnosis industry include Exact Sciences, Grail, Genetron Health, New Horizon Health, Burning Rock, Berry Oncology, Shanghai Kunyuan Biotechnology, Oncognostic and Epigenomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Cancer Early Detection and Diagnosis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cancer Early Detection and Diagnosis market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Early Detection and Diagnosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Exact Sciences
  • Grail
  • Genetron Health
  • New Horizon Health
  • Burning Rock
  • Berry Oncology
  • Shanghai Kunyuan Biotechnology
  • Oncognostic
  • Epigenomics
  • Abbott
  • Qiagen
  • iStat Biomedical

Segment by Type

  • Colorectal Cancer
  • Liver Cancer
  • Lung Cancer
  • Other

Segment by Application

  • Hospital
  • Medical Center
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Cancer Early Detection and Diagnosis report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

List of Tables
Table 1. Global Cancer Early Detection and Diagnosis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Colorectal Cancer
Table 3. Key Players of Liver Cancer
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other
Table 6. Global Cancer Early Detection and Diagnosis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cancer Early Detection and Diagnosis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cancer Early Detection and Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Early Detection and Diagnosis Market Share by Region (2018-2023)
Table 10. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Cancer Early Detection and Diagnosis Market Share by Region (2024-2029)
Table 12. Cancer Early Detection and Diagnosis Market Trends
Table 13. Cancer Early Detection and Diagnosis Market Drivers
Table 14. Cancer Early Detection and Diagnosis Market Challenges
Table 15. Cancer Early Detection and Diagnosis Market Restraints
Table 16. Global Cancer Early Detection and Diagnosis Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cancer Early Detection and Diagnosis Market Share by Players (2018-2023)
Table 18. Global Top Cancer Early Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Diagnosis as of 2022)
Table 19. Ranking of Global Top Cancer Early Detection and Diagnosis Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cancer Early Detection and Diagnosis Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Early Detection and Diagnosis Product Solution and Service
Table 23. Date of Enter into Cancer Early Detection and Diagnosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Early Detection and Diagnosis Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cancer Early Detection and Diagnosis Revenue Market Share by Type (2018-2023)
Table 27. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Cancer Early Detection and Diagnosis Revenue Market Share by Type (2024-2029)
Table 29. Global Cancer Early Detection and Diagnosis Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cancer Early Detection and Diagnosis Revenue Market Share by Application (2018-2023)
Table 31. Global Cancer Early Detection and Diagnosis Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Cancer Early Detection and Diagnosis Revenue Market Share by Application (2024-2029)
Table 33. North America Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Cancer Early Detection and Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cancer Early Detection and Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Cancer Early Detection and Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cancer Early Detection and Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Cancer Early Detection and Diagnosis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cancer Early Detection and Diagnosis Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Cancer Early Detection and Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cancer Early Detection and Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cancer Early Detection and Diagnosis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cancer Early Detection and Diagnosis Market Size by Country (2024-2029) & (US$ Million)
Table 48. Exact Sciences Company Detail
Table 49. Exact Sciences Business Overview
Table 50. Exact Sciences Cancer Early Detection and Diagnosis Product
Table 51. Exact Sciences Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 52. Exact Sciences Recent Development
Table 53. Grail Company Detail
Table 54. Grail Business Overview
Table 55. Grail Cancer Early Detection and Diagnosis Product
Table 56. Grail Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 57. Grail Recent Development
Table 58. Genetron Health Company Detail
Table 59. Genetron Health Business Overview
Table 60. Genetron Health Cancer Early Detection and Diagnosis Product
Table 61. Genetron Health Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 62. Genetron Health Recent Development
Table 63. New Horizon Health Company Detail
Table 64. New Horizon Health Business Overview
Table 65. New Horizon Health Cancer Early Detection and Diagnosis Product
Table 66. New Horizon Health Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 67. New Horizon Health Recent Development
Table 68. Burning Rock Company Detail
Table 69. Burning Rock Business Overview
Table 70. Burning Rock Cancer Early Detection and Diagnosis Product
Table 71. Burning Rock Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 72. Burning Rock Recent Development
Table 73. Berry Oncology Company Detail
Table 74. Berry Oncology Business Overview
Table 75. Berry Oncology Cancer Early Detection and Diagnosis Product
Table 76. Berry Oncology Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 77. Berry Oncology Recent Development
Table 78. Shanghai Kunyuan Biotechnology Company Detail
Table 79. Shanghai Kunyuan Biotechnology Business Overview
Table 80. Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Product
Table 81. Shanghai Kunyuan Biotechnology Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 82. Shanghai Kunyuan Biotechnology Recent Development
Table 83. Oncognostic Company Detail
Table 84. Oncognostic Business Overview
Table 85. Oncognostic Cancer Early Detection and Diagnosis Product
Table 86. Oncognostic Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 87. Oncognostic Recent Development
Table 88. Epigenomics Company Detail
Table 89. Epigenomics Business Overview
Table 90. Epigenomics Cancer Early Detection and Diagnosis Product
Table 91. Epigenomics Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 92. Epigenomics Recent Development
Table 93. Abbott Company Detail
Table 94. Abbott Business Overview
Table 95. Abbott Cancer Early Detection and Diagnosis Product
Table 96. Abbott Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 97. Abbott Recent Development
Table 98. Qiagen Company Detail
Table 99. Qiagen Business Overview
Table 100. Qiagen Cancer Early Detection and Diagnosis Product
Table 101. Qiagen Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 102. Qiagen Recent Development
Table 103. iStat Biomedical Company Detail
Table 104. iStat Biomedical Business Overview
Table 105. iStat Biomedical Cancer Early Detection and Diagnosis Product
Table 106. iStat Biomedical Revenue in Cancer Early Detection and Diagnosis Business (2018-2023) & (US$ Million)
Table 107. iStat Biomedical Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Early Detection and Diagnosis Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cancer Early Detection and Diagnosis Market Share by Type: 2022 VS 2029
Figure 3. Colorectal Cancer Features
Figure 4. Liver Cancer Features
Figure 5. Lung Cancer Features
Figure 6. Other Features
Figure 7. Global Cancer Early Detection and Diagnosis Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Cancer Early Detection and Diagnosis Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Medical Center Case Studies
Figure 11. Other Case Studies
Figure 12. Cancer Early Detection and Diagnosis Report Years Considered
Figure 13. Global Cancer Early Detection and Diagnosis Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Cancer Early Detection and Diagnosis Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cancer Early Detection and Diagnosis Market Share by Region: 2022 VS 2029
Figure 16. Global Cancer Early Detection and Diagnosis Market Share by Players in 2022
Figure 17. Global Top Cancer Early Detection and Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Diagnosis as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Early Detection and Diagnosis Revenue in 2022
Figure 19. North America Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Cancer Early Detection and Diagnosis Market Share by Country (2018-2029)
Figure 21. United States Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cancer Early Detection and Diagnosis Market Share by Country (2018-2029)
Figure 25. Germany Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cancer Early Detection and Diagnosis Market Share by Region (2018-2029)
Figure 33. China Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cancer Early Detection and Diagnosis Market Share by Country (2018-2029)
Figure 41. Mexico Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cancer Early Detection and Diagnosis Market Share by Country (2018-2029)
Figure 45. Turkey Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Cancer Early Detection and Diagnosis Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Exact Sciences Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 48. Grail Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 49. Genetron Health Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 50. New Horizon Health Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 51. Burning Rock Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 52. Berry Oncology Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 53. Shanghai Kunyuan Biotechnology Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 54. Oncognostic Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 55. Epigenomics Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 56. Abbott Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 57. Qiagen Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 58. iStat Biomedical Revenue Growth Rate in Cancer Early Detection and Diagnosis Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock